Obinutuzumab — Uses, Dosage, Side Effects & Safety
Drug class: Monoclonal Antibody, Anti-CD20, Antineoplastic Agent
Overview
Obinutuzumab is a prescription medicine used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). It is often used in combination with other chemotherapy drugs. Obinutuzumab works by targeting a protein called CD20 found on the surface of B-cells, a type of white blood cell. By binding to this protein, it helps your immune system destroy these abnormal cells. Key points for patients: Obinutuzumab is given as an intravenous (IV) infusion in a healthcare setting. It can cause infusion-related reactions, especially with the first dose. Your doctor will monitor you closely during treatment. Tell your healthcare provider about any infections or recent vaccinations before starting therapy.
Frequently Asked Questions about Obinutuzumab
What conditions does Obinutuzumab treat?
Obinutuzumab is used to treat chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL), often in combination with other chemotherapy agents.
How is Obinutuzumab given?
It is administered as an intravenous infusion by a healthcare professional in a hospital or clinic setting.
What are the most common side effects?
Common side effects include infusion-related reactions (fever, chills), low white blood cell counts, fatigue, cough, and diarrhea.
Can I receive vaccines while on Obinutuzumab?
You should avoid live vaccines during and after treatment. Discuss all vaccinations with your healthcare provider before starting therapy.
What should I do if I miss a dose?
Contact your healthcare provider immediately to reschedule your missed infusion. Do not attempt to self-administer the medication.
Is Obinutuzumab safe during pregnancy or breastfeeding?
Obinutuzumab may harm an unborn baby. Use effective contraception during treatment and for at least 6 months after the last dose. Breastfeeding is not recommended during treatment and for at least 6 months after the last dose.
How long does treatment with Obinutuzumab last?
Treatment duration depends on your diagnosis and response to therapy. For CLL and FL, it is typically given in cycles over several months. Your doctor will determine the exact schedule.
Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.